Biotech Analyst Devarakonda along with CEO Cohen and CFO Moran discuss CB1R Inverse agonist designed to boost GLP1 efficacy on a conference call to be held on September 5 at 10 am hosted by Truist.Webcast Link
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRBP:
- Corbus Pharmaceuticals Announces Board Changes and New Compensation Plans
- Corbus Pharmaceuticals appoints Kung to board of directors
- Corbus Pharmaceuticals Strengthens Board of Directors with Appointment of Winston Kung
- Corbus Pharmaceuticals participates in a conf call hosted by Cantor Fitzgerald
- Corbus Pharmaceuticals price target raised to $88 from $80 at Oppenheimer